Akèy › Alòpesi
Etid klinik pou Alòpesi ap rekrite nan Etazini
21 etid pou Alòpesi ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
Pa eta
- Alabama3 etid
- Florid4 etid
- Indiana3 etid
- Kalifòni7 etid
- Maryland4 etid
- New York5 etid
- Ohio3 etid
- Tennessee3 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
1470nm Laser for the Treatment of Androgenetic Alopecia and Scarring Alopecia
Ap rekriteVolontè an sante akeyi
Laj 18 a 99 · Tout sèks · Mizajou Oct 1, 2026 · NCT05460611Tirzepatide for Treatment of CCCA
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 23, 2026 · NCT07734870A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
Ap rekriteFaz 3
Laj 12 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT06873945HCW9302 (Interleukin-2 Fusion Protein) for Alopecia Areata
Ap rekriteFaz 1
Laj 18 a 70 · Tout sèks · Mizajou Sep 15, 2026 · NCT07049328Dual Modality Treatment of Androgenic Alopecia With KeraFactor® Solution and Revian® LED Light Therapy
Ap rekrite
Laj 35 a 55 · Fanm · Mizajou Sep 9, 2026 · NCT07810504A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
Ap rekriteFaz 3
Laj 6 a 17 · Tout sèks · Mizajou Sep 8, 2026 · NCT05723198Blood Specimen Collection For Laboratory Assay Research
Ap rekriteEtid obsèvasyonMande peman pou patisipan yo
Laj 18 ak plis · Tout sèks · Mizajou Aug 13, 2026 · NCT06046651Scalp Cooling for Chemotherapy-Induced Alopecia in Patients of Color
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 16, 2026 · NCT05213936Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia Areata
Ap rekriteFaz 2Volontè an sante akeyi
Laj 12 a 75 · Tout sèks · Mizajou Jun 22, 2026 · NCT05398809A Study of LAD603 in Adults With Alopecia Areata
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou May 20, 2026 · NCT07311564Study Of Cold Cap Therapy For Prevention of Hairloss in Pediatric Patients Receiving Chemotherapy For Non-Malignant Indications and Solid Tumors
Ap rekrite
Laj 7 ak plis · Tout sèks · Mizajou May 1, 2026 · NCT04764357Treatment Results for Patients With Central Centrifugal Cicatricial Alopecia (CCCA): a Multicenter Prospective Study
Ap rekriteFaz 4
Laj 18 a 60 · Fanm · Mizajou Mar 31, 2026 · NCT04207931Evaluation of Scalp Cooling During Chemotherapy on Quality of Life and the Potential Role of Single Nucleotide Variations on Chemotherapy-Induced Alopecia and Hair Regrowth in the Appalachian Highlands Region
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Feb 20, 2026 · NCT07422376Autologous Hair Follicle Secretome for Androgenic Alopecia (Single Site)
Ap rekriteVolontè an sante akeyi
Laj 18 a 65 · Tout sèks · Mizajou Feb 12, 2026 · NCT07107841Clinical Study to Evaluate the Improvement in Hair Loss in Skin of Color Treated With Fractional Non-Ablative Laser
Ap rekriteVolontè an sante akeyi
Laj 21 a 55 · Tout sèks · Mizajou Jan 2, 2026 · NCT06885112Non-Ablative Laser to Treat Scarring Alopecia With Hair Follicle Gene Expression Analysis
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Dec 15, 2025 · NCT06946550Effects of Using a Storybook, to Explain Leukemia to Children Versus the Standard Child Life Intervention, on Parental Stress.
Ap rekriteVolontè an sante akeyi
Laj 3 ak plis · Tout sèks · Mizajou Aug 3, 2025 · NCT06360718Evaluating the Combined Use of Supplement and Serum in Promoting Hair Growth in Women With Self-perceived Thinning Hair
Ap rekriteVolontè an sante akeyi
Laj 28 a 65 · Fanm · Mizajou Jun 27, 2025 · NCT07041489Autologous Adipose Cells Therapy
Ap rekriteFaz 1/2
Laj 21 a 80 · Tout sèks · Mizajou May 31, 2025 · NCT06869252Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss
Ap rekrite
Laj 21 ak plis · Fanm · Mizajou Apr 6, 2025 · NCT05484973Computer-Assisted Hair Restoration Study Using ARTAS System
Ap rekrite
Laj 20 a 70 · Gason · Mizajou Aug 26, 2024 · NCT05938569Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.